Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (141-150 of 283) with videos related to

Pageof 29
Sort By:
International Journal of Alzheimer'S Disease|December 7, 2011
Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer DementiaPhilipp Spitzer, Heinke Schieb, Heike Kamrowski-Kruck, et al.
Multiple Sclerosis and Related Disorders|August 13, 2019
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosisLorenzo Gaetani, Paolo Eusebi, Andrea Mancini, et al.
Journal of Alzheimer'S Disease : JAD|December 3, 2016
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian SelfieGiulia M Sancesario, Sofia Toniolo, Davide Chiasserini, et al.
Clinical Parkinsonism & Related Disorders|October 6, 2025
Changes in the olfactory tract of patients with early Parkinson's disease: A DTI tractography studyPasquale Nigro, Andrea Chiappiniello, Filippo Bucherini, et al.
International Journal of Molecular Sciences|April 30, 2021
Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential DiagnosisGiulia Menculini, Elena Chipi, Federico Paolini Paoletti, et al.
Neuromolecular Medicine|February 23, 2012
Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patientsGaetano Gorgone, Monica Currò, Nadia Ferlazzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 9, 2022
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's diseaseLorenzo Barba, Samir Abu Rumeileh, Giovanni Bellomo, et al.
Cephalalgia : an International Journal of Headache|June 17, 2026
CGRP, VIP and PACAP plasmatic levels in migraine patients before and after anti-CGRP(R) monoclonal antibodies treatmentDavide Chiasserini, Alessia Bellotti, Alfredo Megaro, et al.
Alzheimer'S Research & Therapy|January 27, 2018
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluationLorenzo Gaetani, Kina Höglund, Lucilla Parnetti, et al.
Multiple Sclerosis and Related Disorders|December 5, 2022
Clinical correlates of state and trait anxiety in multiple sclerosisGiulia Menculini, Lucia Gentili, Lorenzo Gaetani, et al.
Pageof 29

Showing results (141-150 of 283) with videos related to

Sort By:
Pageof 29
International Journal of Alzheimer'S Disease|December 7, 2011
Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer DementiaPhilipp Spitzer, Heinke Schieb, Heike Kamrowski-Kruck, et al.
Multiple Sclerosis and Related Disorders|August 13, 2019
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosisLorenzo Gaetani, Paolo Eusebi, Andrea Mancini, et al.
Journal of Alzheimer'S Disease : JAD|December 3, 2016
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian SelfieGiulia M Sancesario, Sofia Toniolo, Davide Chiasserini, et al.
Clinical Parkinsonism & Related Disorders|October 6, 2025
Changes in the olfactory tract of patients with early Parkinson's disease: A DTI tractography studyPasquale Nigro, Andrea Chiappiniello, Filippo Bucherini, et al.
International Journal of Molecular Sciences|April 30, 2021
Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential DiagnosisGiulia Menculini, Elena Chipi, Federico Paolini Paoletti, et al.
Neuromolecular Medicine|February 23, 2012
Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patientsGaetano Gorgone, Monica Currò, Nadia Ferlazzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 9, 2022
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's diseaseLorenzo Barba, Samir Abu Rumeileh, Giovanni Bellomo, et al.
Cephalalgia : an International Journal of Headache|June 17, 2026
CGRP, VIP and PACAP plasmatic levels in migraine patients before and after anti-CGRP(R) monoclonal antibodies treatmentDavide Chiasserini, Alessia Bellotti, Alfredo Megaro, et al.
Alzheimer'S Research & Therapy|January 27, 2018
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluationLorenzo Gaetani, Kina Höglund, Lucilla Parnetti, et al.
Multiple Sclerosis and Related Disorders|December 5, 2022
Clinical correlates of state and trait anxiety in multiple sclerosisGiulia Menculini, Lucia Gentili, Lorenzo Gaetani, et al.
Pageof 29